Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound. Their study, published ...
Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
German pharmaceutical firm Boehringer Ingelheim has selected Certara's D360 as its global drug discovery platform, which will help in sharing discovery data across global working groups that can include external collaborators. Certara is ...
Japanese drugmaker Otsuka Pharmaceutical has agreed to acquire Astex Pharmaceuticals for $866m in an all-cash tender offer. Under the deal, Astex's fragment-based drug design technology called 'PYRAMID' will be integrated into Otsuka, ...
Sunovion Pharma and San Diego-based drug discovery platform company Afraxis have entered into a partnership agreement to use the unique enhanced spine platform (ESP), to boost Sunovion’s preclinical central nervous system (CNS) drug ...
Tags: Sunovion Pharma, Afraxis
Inventiva and Novalix have entered into a strategic alliance to discover the clinical candidates, targeting nuclear receptors. As part of the agreement, Inventiva and NovAliX offer pharmaceutical and biotech companies a set of fully ...
Tags: NovAliX, clinical candidates
Proteros biostructures has collaborated with Priaxon to develop lead compounds for high value protein-protein interaction (PPI) drug targets. The combination of Proteros' structure guided discovery with Priaxon's PPI-directed drug ...
Tags: Proteros, Priaxon Collaborate, PPI Drug
Evotec has reached a milestone in drug discovery collaboration with Ono Pharmaceutical with the progression of a compound into pre-clinical development. The advancement of the compound into the pre-clinical development triggers an agreed ...
Tags: Evotec, drug, Ono Pharmaceutical
Priaxon has signed research collaboration with GlaxoSmithKline (GSK) to develop small molecule modulators for various protein-protein-interactions (PPIs). The collaboration will utilize Priaxon's small molecule drug discovery knowledge in ...
Tags: Priaxon, GSK, drug discovery, clinical development, therapeutic areas
Evotec and Haplogen have signed a drug discovery partnership targeting viral infectious diseases. The drugs resulting from the partnership are expected to target a human protein that is vital for the spread of pathogenic viral ...
Tags: the human protein, targeting viral infectious diseases, Haplogen, Evotec
Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule Therapeutics for protein-protein interactions As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and ...
Tags: Full Spectrum Genetics, BioBlocks, new small molecule therapeutics
BioFocus, the Galapagos' service division, and Ono Pharmaceutical have signed a new drug discovery agreement focusing on CNS disorders. BioFocus managing director and Galapagos Services SVP Dr. Chris Newton said, "This project plays to ...
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier. Under the drug discovery program, Vernalis will receive a payment of €0.5m from Servier on ...
Tags: drug discovery platforms, oncology drug discovery, undisclosed oncology